Cargando…

4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.

OBJECTIVES/GOALS: Autism spectrum disorder (ASD) is a developmental disorder with a high financial and personal burden. Individuals with ASD experience significant comorbid medical conditions. We identified conditions that appear prior to ASD diagnosis in order to potentially improve early screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Failla, Michelle D, Schwartz, Kyle, Chaganti, Shikha, Woynaroski, Tiffany G, Cutting, Laurie, Landman, Bennett, Cascio, Carissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822913/
http://dx.doi.org/10.1017/cts.2020.170
_version_ 1784646701524451328
author Failla, Michelle D
Schwartz, Kyle
Chaganti, Shikha
Woynaroski, Tiffany G
Cutting, Laurie
Landman, Bennett
Cascio, Carissa
author_facet Failla, Michelle D
Schwartz, Kyle
Chaganti, Shikha
Woynaroski, Tiffany G
Cutting, Laurie
Landman, Bennett
Cascio, Carissa
author_sort Failla, Michelle D
collection PubMed
description OBJECTIVES/GOALS: Autism spectrum disorder (ASD) is a developmental disorder with a high financial and personal burden. Individuals with ASD experience significant comorbid medical conditions. We identified conditions that appear prior to ASD diagnosis in order to potentially improve early screening practices. METHODS/STUDY POPULATION: We used electronic health record data from an anonymized database at Vanderbilt University Medical Center for individuals with ASD and matched controls to analyze comorbid conditions prior to an ASD diagnosis. Data were censored to include only individuals who first appeared in the databank prior to two years of age (n(total) = 1551, n(controls) = 976, n(ASD) = 575). Comorbidities (~1800 conditions) were compared between the ASD and matched control group using a novel tool (pyPheWAS) to examine presence, count, and duration of comorbidities that occurred between 0-2 years old and before ASD diagnosis. RESULTS/ANTICIPATED RESULTS: Convulsions (p = 0.000404, ß = 0.807), constipation (p = 0.000789, ß = 0.894), and strabismus (p = 0.00243, ß = 1.155) were the most significant comorbid conditions prior to age 2 in individuals who would later be diagnosed with ASD. The group with ASD also had more visits associated with convulsions (p = 0.00511, ß = 0.195), diseases of the esophagus (p = 0.0117, ß = 1.675), and allergic reactions to food (p = 0.0119, ß = 0.540) prior to their diagnosis. The ASD group was also seen for a longer duration regarding convulsions (p = 0.000273, ß = 0.695), constipation (p = 0.00157, ß = 0.712), and malaise and fatigue (p = 0.00188, ß = 0.903) before ASD diagnosis. DISCUSSION/SIGNIFICANCE OF IMPACT: Precise comorbid condition profiles in early childhood may help uncover biomarkers leading to better prediction of a future ASD diagnosis. Medical conditions that precede the onset of measurable behavioral symptoms may enhance early screening, treatment, and intervention in ASD.
format Online
Article
Text
id pubmed-8822913
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88229132022-02-18 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. Failla, Michelle D Schwartz, Kyle Chaganti, Shikha Woynaroski, Tiffany G Cutting, Laurie Landman, Bennett Cascio, Carissa J Clin Transl Sci Data Science/Biostatistics/Informatics OBJECTIVES/GOALS: Autism spectrum disorder (ASD) is a developmental disorder with a high financial and personal burden. Individuals with ASD experience significant comorbid medical conditions. We identified conditions that appear prior to ASD diagnosis in order to potentially improve early screening practices. METHODS/STUDY POPULATION: We used electronic health record data from an anonymized database at Vanderbilt University Medical Center for individuals with ASD and matched controls to analyze comorbid conditions prior to an ASD diagnosis. Data were censored to include only individuals who first appeared in the databank prior to two years of age (n(total) = 1551, n(controls) = 976, n(ASD) = 575). Comorbidities (~1800 conditions) were compared between the ASD and matched control group using a novel tool (pyPheWAS) to examine presence, count, and duration of comorbidities that occurred between 0-2 years old and before ASD diagnosis. RESULTS/ANTICIPATED RESULTS: Convulsions (p = 0.000404, ß = 0.807), constipation (p = 0.000789, ß = 0.894), and strabismus (p = 0.00243, ß = 1.155) were the most significant comorbid conditions prior to age 2 in individuals who would later be diagnosed with ASD. The group with ASD also had more visits associated with convulsions (p = 0.00511, ß = 0.195), diseases of the esophagus (p = 0.0117, ß = 1.675), and allergic reactions to food (p = 0.0119, ß = 0.540) prior to their diagnosis. The ASD group was also seen for a longer duration regarding convulsions (p = 0.000273, ß = 0.695), constipation (p = 0.00157, ß = 0.712), and malaise and fatigue (p = 0.00188, ß = 0.903) before ASD diagnosis. DISCUSSION/SIGNIFICANCE OF IMPACT: Precise comorbid condition profiles in early childhood may help uncover biomarkers leading to better prediction of a future ASD diagnosis. Medical conditions that precede the onset of measurable behavioral symptoms may enhance early screening, treatment, and intervention in ASD. Cambridge University Press 2020-07-29 /pmc/articles/PMC8822913/ http://dx.doi.org/10.1017/cts.2020.170 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Data Science/Biostatistics/Informatics
Failla, Michelle D
Schwartz, Kyle
Chaganti, Shikha
Woynaroski, Tiffany G
Cutting, Laurie
Landman, Bennett
Cascio, Carissa
4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
title 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
title_full 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
title_fullStr 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
title_full_unstemmed 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
title_short 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
title_sort 4420 characterizing medical comorbidity prior to autism diagnosis in children before age two.
topic Data Science/Biostatistics/Informatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822913/
http://dx.doi.org/10.1017/cts.2020.170
work_keys_str_mv AT faillamichelled 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo
AT schwartzkyle 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo
AT chagantishikha 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo
AT woynaroskitiffanyg 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo
AT cuttinglaurie 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo
AT landmanbennett 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo
AT casciocarissa 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo